Natural molecule appears to shut off cancer cells' energy sourceSeptember 14, 2017
DURHAM, N.C. -- The Warburg Effect describes a phenomenon in which cancer cells voraciously consume glucose for energy -- something scientists have long known, yet have had little success exploiting as a way to stunt tumor growth.
Now researchers at Duke Cancer Institute have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.
"The Warburg Effect has been known for decades, but the underlying mechanisms are not well understood," said Jason Locasale, assistant professor in the Department of Pharmacology & Cancer Biology at Duke and senior author of a study published Sept. 14 in the journal Cell Metabolism. "We started with the idea that if you understand how it works, you should be better able to control it, and we think we might have some insight on that, as well."
Locasale and colleagues, including lead author Maria Liberti, studied cancer cells to determine how their metabolism changes so dramatically from that of normal cells, which use oxygen to break down sugar. Cancer cells, instead, use fermentation, which is less efficient and therefore uses more sugar.
The researchers found particular points where carbohydrate metabolism is controlled differently in cancer cells undergoing the Warburg Effect, and they homed in on an enzyme, identified as GAPDH, that controls the rate at which glucose is processed in cancer cells.
And while the Warburg Effect is strong in many cancers, it's absent or weaker in others. By measuring the GAPDH enzyme, the Duke team was able to develop a predictive model to measure how extensively cancer cells are under the influence of the Warburg Effect. Where the effect is strongest, the tumors could potentially be vulnerable to a therapy that targets the process.
"We've seen with genetics that cancers can be targeted based on whether certain mutations are present, and it could be that selectively targeting tumors based on their metabolism could have a similar impact," Liberti said.
Armed with their findings, the researchers then scoured the literature to see if there were any known compounds that might block the GAPDH enzyme. One molecule called koningic acid, or KA, seemed to have potential. It was discovered 30 years as part of a search to find drugs that lower cholesterol. That quest led to statins, and KA was abandoned.
The molecule is produced by a sugar-eating fungus that colonizes sugar-rich environments such as sweet potatoes. The fungus generates KA to ward off bacteria that might try stealing its sugar source. Suspecting that KA might be a natural molecule that targets organisms or systems involved in accelerated glucose metabolism, the researchers tested the molecule in cancer cells and mouse models.
They found that KA does, indeed, selectively inhibit the GAPDH enzyme, curbing the ravenous glucose consumption in tumors undergoing the Warburg Effect and leaving normal cells alone.
Locasale said their findings warrant further study, notably to determine whether KA's effects can be reproduced in additional animal and cell studies and whether other drug-like molecules might work along the same energy pathway.
"These findings not only show that KA's efficacy is linked to the quantitative extent of the Warburg Effect, but that this also provides a therapeutic window," Locasale said. "This could provide another way to attack cancer beyond the genetic makeup of the tumor. That's encouraging."
The research received support from the National Institutes of Health (T32GM007273, R01CA193256, R00CA168997, R01CA174643, T32GM008500), the National Science Foundation, the American Cancer Society, the Sloan Foundation, the International Life Sciences Institute, and the Canadian Institutes of Health Research.
Authors Locasale and Liberti are listed on a filing for a provisional patent related to this work.
Duke University Medical Center
Related Cancer Cells Articles:
Researchers at University of California San Diego School of Medicine report that cancer cells appear to communicate to other cancer cells, activating an internal mechanism that boosts resistance to common chemotherapies and promotes tumor survival.
Researchers have identified a protein that must be present in order for mammary stem cells to perform their normal functions.
A gene previously identified as critical for tumor growth in many human cancers also maintains intestinal stem cells and encourages the growth of cells that support them, according to results of a study led by Johns Hopkins researchers.
Advanced prostate cancer and high blood cholesterol have long been known to be connected, but it has been a chicken-or-egg problem.
Princess Margaret Cancer Centre scientists have discovered a distinct cell population in tumours that inhibits the body's immune response to fight cancer.
Researchers have developed an artificial structure that mimics the cell membrane, which can switch on immune cells to attack and destroy a designated target.
Researchers have identified a unique subset of these cells that exhibit hybrid characteristics of two immune cell types -- neutrophils and antigen-presenting cells -- in samples from early-stage human lung cancers.
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Tiny bubbles filled with the sleep hormone melatonin can make breast cancer treatment more effective, which means people need a lower dose, giving them less severe side effects.
Baylor College of Medicine researchers report a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.
Related Cancer Cells Reading:
Essential Oils And Cancer: How To Effectively Use The Right Essential Oils To Confuse And Kill Cancer Cells
by Nancy Dennett Ducharme (Author)
Essential oils have been used for centuries to help support the immune system and bring the body back to health. This first book in the Essential Oils And Cancer series shows step by step exactly how to use essential oils to fight cancer. Learn how to prepare and use the compounds in two specific plant species to attack and destroy abnormal cells and cell mutations that have grown out of control. Learn which combinations of essential oils to use with breast cancer, bone cancer, lung cancer, skin cancer, prostate cancer, and other cancers according to latest scientific research. View Details
One Renegade Cell: How Cancer Begins (Science Masters Series)
by Robert A. Weinberg (Author)
Cancer research has reached a major turning point, and no one is better qualified to explain the past two deacades' dramatic leaps forward in understanding this disease than world-renowned molecular biologist Robert Weinberg, director of the Oncology Research Laboratory at the Whitehead Institute in Cambridge, Massachusetts. In One Renegade Cell, Weinberg presents a state-of-the-art account of how cancer begins and how, one day, it will be cured. View Details
NCCN Guidelines for Patients®: Lung Cancer (Non-Small Cell), Version 1.2016
by National Comprehensive Cancer Network® (NCCN®) (Author)
[OFFICIAL CURRENT VERSION] From the medical leaders of 27 of the world’s most renowned cancer centers united under the National Comprehensive Cancer Network® (NCCN®), comes this essential guide to lung cancer (non-small cell lung cancer). Adapted from clinical treatment guidelines used by physicians and oncology professionals around the world, these NCCN Guidelines for Patients® are packed with the latest information, treatment innovations, and resources about the diagnosis and treatment of lung cancer. Each patient-friendly chapter prepares patients and caregivers to talk with their... View Details
How To Kill Cancer Cells: Make Your Body Healthy Now
by Natalie Mitchell (Author)
Natalie Mitchell’s Amazon Best Seller second book “How To Kill Cancer Cells” sets out clear guidelines for readers to create a bodily environment in which cancer cells cannot thrive. Everybody has cancer cells and with the medical technology available nowadays doctors can only diagnose cancer disease when people already have developed BILLIONS of active cancer cells in their body. While the information itself is easy to understand, the Author’s clear message is that we, as individuals, can control our susceptibility to Cancer, eliminate Cancer cells and prevent and avoid the disease... View Details
The 20 herbs that can kill the cancer cells: For every person who believes that herbs and plants can slow or even kill cancer
Cаnсеr is unсоntrоllеd grоwth of аbnоrmаl сеllѕ in thе body. Normally, mеiоѕiѕ аnd cell death рrосеdurе occurs to рrоtесt stable соnditiоn оf tiѕѕuеѕ in bаlаnсеd state. Cаrсinоgеnеѕiѕ is a multiѕtаgе оr multi mесhаniѕm procedure. Thе initiаl ѕtаgе оf саnсеr inсludеѕ irrеvеrѕiblе сеll changes.
Mоrе and more people who have been diаgnоѕеd with саnсеr оr rеlаtеd illnesses еmbrасе alternative medicines, аnd ѕееk оut hоliѕtiс рrасtitiоnеrѕ whо use vitаminѕ, herbs, nutrition,... View Details
Cancer: The Outlaw Cell
by Richard LaFond (Editor)
We live in an era in which scientific information grows by the day and is so specialized that no one person can possibly absorb and kept abreast of the literature. Substantial developments in science and medicine, powered by developing technologies such as genetic sequencing, proteomics, and nanobiology, have driven cancer research forward, and a review of where we are now is desperately needed.
Cancer: The Outlaw Cell is a collection of twenty-five focused chapters written by leading researchers at the forefront of cancer research. Authors present the current state of... View Details
Small Cell Lung Cancer - Treatment Options and Alternative Medicine
by Christian Vazquez (Author)
Small Cell Lung Cancer is a full crash course on the topic. We reviewed over 300 of the strongest natural agents that exist for cancer and found only 6 that have conclusive evidence for small cell lung cancer. The biggest problem is not lack of information in the world, it is the lack of time, understanding of the medical data associated with scientific research and to top it off there is so much data in so many directions between the pharmaceutical, people trying to steer you in the wrong way to make a quick dollar, the quacks of the industry and everything else imaginable where at the end... View Details
The Cancer Fighting Diet: Diet and Nutrition Strategies to Help Weaken Cancer Cells and Improve Treatment Results
by Dr. Johannes Coy Sc.D. (Author), Maren Franz (Author)
This book provides basic information about cancer, as well as detailed advice and a comprehensive diet plan to help fight a personal battle with cancer and significantly improve chances of a cure.
There are complex processes inside the human body and specific mechanisms that can lead to the development and spread of cancer cells. Understanding the causes for what is happening inside the body is the key to implementing the recommendations in this guide.
Using these recipes and nutritional strategies will cut dramatically down on sugar in order to deplete the strength and... View Details
The Immortal Life of Henrietta Lacks
by Rebecca Skloot (Author)
Now an HBO® Film starring Oprah Winfrey and Rose Byrne
#1 NEW YORK TIMES BESTSELLER
Her name was Henrietta Lacks, but scientists know her as HeLa. She was a poor black tobacco farmer whose cells—taken without her knowledge in 1951—became one of the most important tools in medicine, vital for developing the polio vaccine, cloning, gene mapping, and more. Henrietta's cells have been bought and sold by the billions, yet she remains virtually unknown, and her family can't afford health insurance. This phenomenal New York Times bestseller tells a riveting story... View Details
Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy (Resistance to Targeted Anti-Cancer Therapeutics)
by Emmanuel Donnadieu (Editor)
This volume focuses on recent advances in understanding T cells as key players in antitumor immune responses, and as a result T cell-based immunotherapy is starting to transform the treatment of advanced cancers. However, despite recent successes, many patients with cancer fail to respond to these treatments. Defective migration of T cells into and within tumors is considered as an important resistance mechanism to cancer immunotherapy.The volume includes three sections. The first section covers general knowledge about T cell trafficking during a normal immune response but also during tumor... View Details